Australia markets closed

Botanix Pharmaceuticals Limited (BOT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1800-0.0050 (-2.70%)
At close: 03:42PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 289.24M
Enterprise value 280.55M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.07k
Price/book (mrq)12.60
Enterprise value/revenue 2.73k
Enterprise value/EBITDA -31.31

Trading information

Stock price history

Beta (5Y monthly) 1.79
52-week change 3143.42%
S&P500 52-week change 324.01%
52-week high 30.2100
52-week low 30.0740
50-day moving average 30.1778
200-day moving average 30.1504

Share statistics

Avg vol (3-month) 33.27M
Avg vol (10-day) 31.76M
Shares outstanding 51.56B
Implied shares outstanding 61.56B
Float 81.2B
% held by insiders 116.35%
% held by institutions 19.74%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:3
Last split date 316 June 2016

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)30 June 2023


Profit margin -242.66%
Operating margin (ttm)1,583.62%

Management effectiveness

Return on assets (ttm)-29.35%
Return on equity (ttm)-58.86%

Income statement

Revenue (ttm)3.77M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
Net income avi to common (ttm)-9.15M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)10.25M
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)7.42
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-12.07M
Levered free cash flow (ttm)-15.57M